LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

Search

Moderna Inc

Deschisă

Sector Sănătate

54.03 -0.84

Rezumat

Modificarea prețului

24h

Curent

Minim

53.34

Maxim

55.56

Indicatori cheie

By Trading Economics

Venit

-104M

-1.3B

Vânzări

-167B

241M

P/E

Medie Sector

35.86

104.138

EPS

-3.33

Marjă de profit

-530.705

Angajați

5,600

EBITDA

-109M

-1.2B

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+71.57 upside

Dividende

By Dow Jones

Următoarele câștiguri

7 nov. 2024

Statistici piață

By TradingEconomics

Capitalizare de piață

522M

21B

Deschiderea anterioară

54.87

Închiderea anterioară

54.03

Sentimentul știrilor

By Acuity

100%

0%

373 / 390 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Strong Bullish Evidence

Moderna Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

13 dec. 2023, 13:16 UTC

Principalele dinamici ale pieței

Moderna Shares, Other Covid Vaccine Makers Hit by Warning From Pfizer

3 nov. 2024, 23:34 UTC

Top știri

Stocks Poised for Lower Open -- Barrons.com

28 oct. 2024, 13:48 UTC

Câștiguri

Moderna's Stock-Price Target Slashed. It's About Vaccines. -- Barrons.com

15 sept. 2024, 07:00 UTC

Top știri

World's Biggest Hedge Fund Sells Apple, Eli Lilly Stock, and Buys Microsoft, Moderna -- Barrons.com

12 sept. 2024, 15:02 UTC

Top știri

Moderna Cost Cuts Fail to Restore Investor Trust -- Heard on the Street -- WSJ

12 sept. 2024, 10:00 UTC

Top știri

Moderna Pulls Back on R&D and Delays Timeline for Profitability -- Barrons.com

6 sept. 2024, 11:00 UTC

Top știri

Pandemic Darling Moderna Needs a Reality Check -- Heard on the Street -- WSJ

3 sept. 2024, 04:00 UTC

Top știri

Novo, Amgen, Other Pharma Stocks Have Clinical Trials That Could Send Them Soaring -- Barrons.com

23 aug. 2024, 18:38 UTC

Top știri

The U.S. Is Bringing Back Free Covid Tests This Fall -- Barrons.com

2 aug. 2024, 21:29 UTC

Top știri

The Score: CrowdStrike, Apple, Intel and More Stocks That Defined the Week -- WSJ

1 aug. 2024, 10:30 UTC

Top știri

Moderna Cuts Revenue Guidance Amid Steeper Competition -- Barrons.com

3 iul. 2024, 14:18 UTC

Achiziții, Fuziuni, Preluări

GSK Will Pay Up to $1.5 Billion for CureVac's mRNA Vaccines -- Barrons.com

30 mai 2024, 19:45 UTC

Top știri

Bird Flu Confirmed in Third Farmworker. It's the First Case With Respiratory Symptoms. -- Barrons.com

29 mai 2024, 15:56 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

The Moderna Selloff Gains Steam. An Analyst Has a Few Theories Why. -- Barrons.com

10 mai 2024, 20:11 UTC

Câștiguri

These Stocks Moved the Most Today: Novavax, Akamai, Sweetgreen, Taiwan Semi, Moderna, Gen Digital, JFrog, SoundHound, and More -- Barrons.com

10 mai 2024, 14:49 UTC

Câștiguri
Acțiuni populare

Stocks to Watch Friday: TSMC, Novavax, Nvidia -- WSJ

2 mai 2024, 13:46 UTC

Câștiguri
Acțiuni populare

Stocks to Watch Thursday: Carvana, NIO, Qualcomm, Peloton -- WSJ

2 mai 2024, 10:31 UTC

Câștiguri

Moderna Puts Up Big Quarterly Beat; Could Shares Notch A Breakout? -- IBD

2 mai 2024, 09:08 UTC

Acțiuni populare

Stocks to Watch Thursday: Shell, Novo Nordisk, Apple -- WSJ

28 feb. 2024, 14:14 UTC

Câștiguri

Novavax Stock Sinks as Revenue Misses Estimates in 'Transition Year' -- Barrons.com

22 feb. 2024, 16:00 UTC

Top știri

Moderna Is Pivoting From Covid and the Results Are on Their Way -- Heard on the Street -- WSJ

22 feb. 2024, 12:40 UTC

Câștiguri

Moderna Stock Jumps on Surprise Profit After Earnings Beat. What to Expect in 2024. -- Barrons.com

Comparație

Modificare preț

Moderna Inc Așteptări

Obiectiv de preț

By TipRanks

71.57% sus

Prognoză pe 12 luni

Medie 93.73 USD  71.57%

Maxim 238 USD

Minim 46 USD

În baza a 19 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruModerna Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

19 ratings

7

Cumpărare

10

Păstrare

2

Vânzare

Scor tehnic

By Trading Central

53.05 / 54.76Suport & Rezistență

Termen scurt

Strong Bullish Evidence

Termen mediu

Bearish Evidence

Termen lung

Bearish Evidence

Sentiment

By Acuity

373 / 390 Clasament în Sănătate

Sentimentul știrilor

Evidențe foarte puternice de scădere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Moderna Inc

Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger ribonucleic acid (mRNA), to improve the lives of patients. The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. It is developing vaccines and therapeutics for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases, independently and with its strategic collaborators. The Company develops technologies that enable the development of mRNA medicines for diverse applications. It has created modalities, including prophylactic vaccines, systemic secreted and cell surface therapeutics, cancer vaccines, intratumoral immuno-oncology, and systemic intracellular therapeutics. The Company develops technologies that enable the development of mRNA medicines.